StonvexLoading…
StonvexStonvexStonvexCore line items from MRK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $65.01B | $64.17B | $60.12B | $59.28B |
Operating Income | $21.07B | $19.94B | $1.89B | $16.44B |
Net Income | $18.25B | $17.12B | $365.00M | $14.52B |
EPS (Diluted) | $7.28 | $6.74 | $0.14 | $5.71 |
Total Assets | $136.87B | $117.11B | $106.67B | $109.16B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $14.56B | $13.24B | $6.84B | $12.69B |
Free Cash Flow OCF − CapEx | $12.36B | $18.10B | $9.14B | $14.71B |
Shares Outstanding | 2.51B | 2.54B | 2.55B | 2.54B |